Last reviewed · How we verify
Viaskin Milk 300 mcg — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Viaskin Milk 300 mcg (Viaskin Milk 300 mcg) — DBV Technologies.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Viaskin Milk 300 mcg TARGET | Viaskin Milk 300 mcg | DBV Technologies | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Viaskin Milk 300 mcg CI watch — RSS
- Viaskin Milk 300 mcg CI watch — Atom
- Viaskin Milk 300 mcg CI watch — JSON
- Viaskin Milk 300 mcg alone — RSS
Cite this brief
Drug Landscape (2026). Viaskin Milk 300 mcg — Competitive Intelligence Brief. https://druglandscape.com/ci/viaskin-milk-300-mcg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab